Company profile
UroGen Pharma Ltd. Insider Trading
URGNEvery SEC Form 4 insider trading filing for UroGen Pharma Ltd. (URGN) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001668243
- Filings
- 80
- Insiders
- 12
- Last filing
- 2026-09-08
Activity summary
Recent insider activity is bullish. Over the last 30 days, 6 insiders purchased shares versus 2 sales. Buying was led by Jason Drew Smith.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. UroGen Pharma Ltd. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $3.4M.
90 day insight
Over the last 90 days, UroGen Pharma Ltd. insiders bought $0 (6 transactions) and sold $3.0M (3 transactions).
- Most active insider: Mark Schoenberg with 5 transactions totaling $3.3M.
- Largest single sale: $2.9M by Mark Schoenberg on Aug 20, 2026.
- 25% of recent sales were pre-scheduled 10b5-1 trades, typically less informative than open-market activity.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Jason Drew Smith | URGN | Sale | 1,519 | $42.54 | $65K |
| Sep 8, 2026 | Mark Schoenberg | URGN | Sale | 871 | $42.92 | $37K |
| Sep 7, 2026 | Jason Drew Smith | URGN | Option Exercise | 3,334 | — | — |
| Sep 7, 2026 | Jason Drew Smith | URGN | Option Exercise | 3,334 | — | — |
| Sep 7, 2026 | Mark Schoenberg | URGN | Option Exercise | 1,667 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=URGN" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.